Moreover, it was able to reduce IL-1β, TNF-α and IL-6 over-expressions in both bronchoalveolar lavage fluid (Figure 4C–E) and lung tissues (Figure 4F–H) associated with pulmonary fibrosis. Here, IL1B is linked to pulmonary fibrosis.